FDA Asks: Thoughts on Paperwork for Rare Animal Meds?
Published Date: 2/20/2026
Notice
Summary
The FDA wants your thoughts on how they collect info about new animal drugs for less common animals and uses. This helps make sure these drugs are safe and effective without causing extra paperwork headaches. If you’re involved with these drugs, you’ve got until April 21, 2026, to share your comments—no cost, just your voice!
Analyzed Economic Effects
4 provisions identified: 2 benefits, 2 costs, 0 mixed.
7‑Year Exclusivity for MUMS Sponsors
If you sponsor a designated Minor Use or Minor Species (MUMS) new animal drug, the designation makes you eligible for incentives including a 7‑year period of exclusive marketing rights. The designation is optional but the FDA uses sponsor submissions to determine eligibility for these benefits.
Indexing Lets Some Unapproved Drugs Be Marketed
FDA rules let certain unapproved new animal drugs for minor species be added to an Index so they can be legally marketed for those species. The indexing program is intended to make more medications legally available to veterinarians and animal owners for treatment of minor species.
Estimated Paperwork Burden on Sponsors
FDA estimates the total annual reporting burden for this information collection is 5,562 hours and the total annual recordkeeping burden is 80 hours. FDA reports an overall increase of 60 hours and a corresponding increase of 120 responses and records compared with prior estimates.
Annual Reports, eSubmitter, and Recordkeeping Rules
Sponsors of MUMS‑designated drugs must demonstrate “due diligence” by submitting annual reports documenting progress for each designation and may use FDA's eSubmitter system (access requires a previously established account). Qualified expert panel leaders must keep written reports and related notes for 2 years, and holders of indexed drugs must maintain records of safety or effectiveness information.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11739 — Medical Devices; Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS-CoV-2 Viral Targets From Clinical Specimens in Near-Patient Settings
The FDA is officially putting simple COVID-19 rapid test devices into a safer, easier-to-manage category called Class II. This change means these tests can get to patients faster and with fewer hoops to jump through, while still making sure they work well and stay safe. Starting June 11, 2026, companies making these tests will follow new rules that help speed up innovation without extra costs.
2026-11740 — Medical Devices; Immunology and Microbiology Devices; Classification of the Spinal Muscular Atrophy Newborn Screening Test System
The FDA is officially putting the Spinal Muscular Atrophy (SMA) newborn screening test into class II, meaning it has special safety rules but fewer hurdles than the strictest category. This change helps make the test safer and easier to get to babies who need it, starting June 11, 2026, with the classification effective since November 2022. Labs and device makers will benefit from clearer rules and faster access, helping catch SMA early without extra costs or delays.
2026-11760 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Establishment, Maintenance, and Availability of Records; Additional Traceability Records for Certain Foods
The FDA is asking for approval to collect extra records from food businesses that handle certain high-risk foods. This helps track food sources quickly to keep everyone safe. Food companies should get ready to keep and share these new records, and comments on this plan are due by July 13, 2026.
2026-11762 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products
The FDA is asking for approval to keep collecting info from seafood processors and importers to make sure fish products are safe using a system called HACCP. This affects anyone who processes or imports fish and requires them to keep records showing they’re following safety rules. Comments on this plan are open until July 13, 2026, and there’s no new cost, just a continuation of current paperwork.
2026-11589 — Medical Devices; Ear, Nose, and Throat Devices; Classification of the Combined Acoustic and Electrical External Stimulation Device for the Relief of Tinnitus
The FDA has officially placed the combined acoustic and electrical external stimulation device for tinnitus relief into class II, meaning it now has special safety rules but fewer regulatory hurdles. This change helps patients get access to this innovative device faster and ensures it’s safe and effective. The new classification is effective June 10, 2026, with the rules applying retroactively from March 6, 2023.
2026-11578 — Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information
The FDA just gave a thumbs-up to adding bemotrizinol as a new active ingredient in sunscreens, letting it be used up to 6% concentration. This means sunscreen makers can now include this ingredient, which is safe and effective, in their products. The change is official as of June 10, 2026, and could lead to better sun protection options without extra costs for consumers.
Previous / Next Documents
Previous: 2026-03352 — Agency Information Collection Activities; Proposed Collection; Comment Request; Adverse Events Associated With New Animal Drugs
The FDA wants your thoughts on how it collects reports about problems with new animal drugs and manufacturing issues. This affects drug makers, vets, and pet owners who help spot side effects in animals. Comments are open until April 21, 2026, so jump in now to help shape safer animal medicines without adding extra costs or delays.
Next: 2026-03355 — Presidential Declaration Amendment of a Major Disaster for Public Assistance Only for the State of Tennessee
The President has updated the disaster declaration for Tennessee after a severe winter storm in late January 2026. Now, four more counties—Lawrence, Maury, Robertson, and Wilson—can get public assistance to help recover. If you’re affected, you have until April 7 to apply for physical damage loans and until November 6 for economic injury loans.